Renalytix annual gross margin
2021
2022
2023
2024
Renalytix's gross margin was 6.82% for fiscal 2024.
View full Renalytix company overview| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2024 | 2024-06-30 | 6.82% | −713.18 pp |
| 2023 | 2023-06-30 | 720.00% | +690.57 pp |
| 2022 | 2022-06-30 | 29.43% | −13.03 pp |
| 2021 | 2021-06-30 | 42.45% | — |
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q1 2025 | 2024-09-30 | 19.16% | +28.53 pp |
| Q4 2024 | 2024-06-30 | 6.14% | −10.57 pp |
| Q3 2024 | 2024-03-31 | −12.34% | −52.69 pp |
| Q2 2024 | 2023-12-31 | 32.30% | +4.13 pp |
| Q1 2024 | 2023-09-30 | −9.37% | — |
| Q3 2023 | 2023-03-31 | 16.71% | — |
| Q2 2023 | 2022-12-31 | 40.35% | — |
| Q1 2023 | 2022-09-30 | 28.17% | — |
Across the available reported history, Renalytix's gross margin decreased from 720.00% to 6.82%, a change of −713.18 percentage points. The latest reported quarter, Q1 2025, shows 19.16%.
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Renalytix filings at SEC.gov ↗